Interference of natural mouse hepatitis virus infection with cytokine production and susceptibility to Trypanosoma cruzi

Immunology

Volumn 96, Issue 3, 1999, Pages 381-388

  Torrecilhas, A C T ^a   Faquim Mauro, E ^a   Da Silva, A V ^a   Abrahamsohn, I A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; MONOCLONAL ANTIBODY;

ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; FEMALE; GERMFREE ANIMAL; HELPER CELL; IMMUNE SYSTEM; MOUSE; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; PARASITEMIA; PARASITISM; PRIORITY JOURNAL; SPLEEN CELL; TRYPANOSOMA CRUZI; VIRUS INFECTION; VIRUS VIRULENCE;

ACUTE DISEASE; ANIMALS; CELL CULTURE TECHNIQUES; CHAGAS DISEASE; CHRONIC DISEASE; CORONAVIRUS INFECTIONS; CYTOKINES; DISEASE OUTBREAKS; DISEASE SUSCEPTIBILITY; FEMALE; INTERFERON TYPE II; INTERLEUKIN-10; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MURINE HEPATITIS VIRUS; PARASITEMIA; SPLEEN;

EID: 0033014048     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1999.00719.x     Document Type: Article

References (36)

1. HOMBERGER F.R. (1997) Enterotropic mouse hepatitis virus. Lab Animals 31, 97.
2. COMPTON S.R., BARTHOLD S.W. & SMITH A. (1993) The cellular and molecular pathogenesis of coronaviruses. Lab Animal Sci 43, 15.
3. KIERSZENBAUM F. & SZTEIN M. (1994). Chagas' Disease (American Trypanosomiasis). In: Parasitic Infections and the Immune System (ed. F. KIERSZENBAUM), p. 53. Academic Press, San Diego.
4. ABRAHAMSOHN I.A. (1998) Cytokines in innate and acquired immunity to Trypanosama cruzi infection. Braz J Med Biol Res 31, 117.
5. TARLETON R.L. (1993) Pathology of American trypanosomiasis. In: Immunology and Molecular Biology of Parasitic Infections (ed. K.S. WARREN), p. 64. Blackwell Scientific Publications, Cambridge, MA.
6. TRISHMANN T.M. (1986) Trypanosoma cruzi: early parasite proliferation and host resistance in inbred strains of mice. Exp Parasitol 62, 194.
7. DE GASPARI E.N., UMEZAWA E.S., ZINGALES B., STOLF A.M.S., COLLI W. & ABRAHAMSOHN I.A. (1990) Trypanosoma cruzi: serum antibody reactivity to the parasite antigens in susceptible and resistant mice. Mem Inst Oswaldo Cruz 85, 261.
8. NABORS G.S. & TARLETON R.L. (1991) Differential control of IFN-gamma and IL-2 production during Trypanosoma cruzi infection. J Immunol 146, 3591.
9. CUROTTO-DE-LAFAILLE M.A., BARBOSA-DE OLIVEIRA L.C., LIMA G.M.C. & ABRAHAMSOHN I.A. (1990) Trypanosoma cruzi: maintenance of parasite-specific T cell responses in lymph nodes during the acute phase of the infection. Exp Parasitol 70, 164.
10. SOONG L. & TARLETON R.L. (1994) Trypanosoma cruzi infection suppresses nuclear factors that bind to specific sites on the interleukin-2 enhancer. Eur J Immunol 24, 16.
11. ABRAHAMSOHN I.A. & COFFMAN R.L. (1995) Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection. J Immunol 155, 3955.
12. ABRAHAMSOHN I.A. & COFFMAN R.L. (1996) Trypanosoma cruzi: IL-10, TNF, IFN-γ and IL-12 regulate innate and acquired immunity to infection. Exp Parasitol 84, 231.
13. HUNTER C.A., SLIFER T. & ARAUJO F. (1996) Interleukin-12-mediated resistance to Trypanosoma cruzi is dependent on Tumor Necrosis Factor alpha and Gamma interferon. Infect Immun 64, 2381.
14. ALIBERTI J.C.S., CARDOSO M.A.G., MARTINS G.A., GAZINELLI R.T., VIEIRA L.Q. & SILVA J.S. (1996) Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes. Infect Immun 64, 1961.
15. + lymphocytes increase in vivo susceptibility to Trypanosoma cruzi infection. Cell Immunol 170, 41.
16. HUNTER C.A., ELLIS-NEYES L.A., SUPER T. et al. (1997) IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi. J Immunol 158, 3311.
17. REED S.G., BROWNELL C.E., RUSSO D.M., SILVA J.S., GRABSTEIN K.H. & MORRISSEY P.J. (1994) IL-10 mediates susceptibility to Trypanosoma cruzi infection. J Immunol 153, 3135.
18. PETRAY P.B., ROTTENBERG M.E., BERTOT G. et al. (1993) Effect of anti-gamma-interferon and anti-interleukin-4 administration on the resistance of mice against infection with reticulotropic and myotropic strains of Trypanosoma cruzi. Immunol Letters 35, 77.
19. TADOKORO C.E., MACEDO M.S. & ABRAHAMSOHN I.A. (1996) Saponin adjuvant primes for a dominant interleukin-10 production to ovalbumin and to Trypanosoma cruzi antigen. Immunology 89, 368.
20. BARTHOLD S.W. & SMITH A.L. (1990). Duration of mouse hepatitis virus infection: studies in immunocompetent and chemically immunosuppressed mice. Lab Animal Sci 40, 133.
21. MUNOZ-FERNANDEZ M.A., FERNANDEZ M.A. & FRESNO M. (1992) Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism. Eur J Immunol 22, 301.
22. GAZZINELLI R.T., OSWALD I.P., HIENY S., JAMES S.L. & SHER A. (1992) The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta. Eur J Immunol 22, 2501.
23. SILVA J.S., VESPA G.N., CARDOSO M.A., ALIBERTI J.C. & CUNHA F.Q. (1995). Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages. Infect Immun 63, 4862.
24. LAMONTAGNE L. & JOLICOEUR P. (1994) Low-virulent mouse hepatitis viruses exhibiting various tropisms in macrophages, T and B cell subpopulations, and thymic stromal cells. Lab Animal Sci 44, 17.
25. SMITH A.I., BOTTOMLY K. & WINOGRAD D.F. (1987) Altered splenic T cell function of BALB/cByJ mice infected with mouse hepatitis virus or Sendai virus. J Immunol 138, 3426.
26. DINDZANS V.J., ZIMMERMAN B., SHERKER A. & LEVY G.A. (1987) Susceptibility to mouse hepatitis virus strain 3 in BALB/cJ mice: failure of immune cell proliferation and interleukin 2 production. Adv Exp Med Biol 218, 411.
27. DE SOUZA M.S., SMITH A.I. & BOTTOMLY K. (1991) Infection of BALB/cByJ mice with the JHM strain of mouse hepatitis virus alters in vitro splenic t cell proliferation and cytokine production. Lab Animal Sci 41, 99.
28. DE SOUZA M.S. & SMITH A.L. (1991) Characterization of accessory cell function during acute infection of BALB/cByJ mice with mouse hepatitis virus (MHV), strain JHM. Lab Animal Sci 41, 112.
29. BOOKMAN G.A.M., LUSTER M.I., DEAN J.H. et al. (1982) Peritoneal and macrophage alterations caused by naturally occurring mouse hepatitis virus. Am J Pathol 106, 110.
30. DEMPSEY W.L., SMITH A.L. & MORAHAN P.S. (1986) Effect of inapparent murine hepatitis virus infections on macrophages and host resistance. J Leuk Biol 39, 559.
31. PARRA B., HINTON D.R., LIN M.T., CUA D.J. & STOHLMAN S.A. (1997) Kinetics of cytokinc mRNA expression in the central nervous system following lethal and non-lethal coronavirus-induced acute encephalomyelitis. Virology 233, 260.
32. EVEN C., ROWLAND R.R.R. & PLAGEMANN P.G.W. (1995) Mouse hepatitis virus infection of mice causes long-term depletion of lactate dehydrogenase-elevating virus-permissive macrophages and T lymphocyte alterations. Virus Res 39, 355.
33. LARDANS V., GODFRAIND C, VAN DER LOGT J.T.M., HEESSSEN F.W.A., GONZALEZ M.D. & COUTELIER J.P. (1996). Polyclonal B lymphocyte activation induced by mouse hepatitis virus A59 infection. J Gen Virol 77, 1005.
34. COOK-MILLS J.M., MUNSHI H.G., PERLMAN R.L. & CHAMBERS D.A. (1992) Mouse hepatitis virus suppresses modulation of mouse spleen T cell activation. Immunology 75, 542.
35. RANGEL H.A., VERINAUD L., CAMARGO I.J.B., GILIOLI R. & SAKURADA J.K. (1994) Murine virus contaminant of Trypanosoma cruzi experimental infection. Rev Inst Med Trop São Paulo 36, 423.
36. RANGEL H.A., VERINAUD L., CAMARGO I.J.B., GILIOLI R. & SAKURADA J.K. (1994) Trypanosoma cruzi: Murine virus contaminant of the experimental infection. Exp Parasitol 78, 429.